LONDON, Dec. 10, 2018 (GLOBE NEWSWIRE) -- ADL Bionatur Solutions (ADL-BS) was formed through the reverse...
EMERYVILLE, Calif. and LEÓN, Spain, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT...
TUSTIN, Calif., Sept. 18 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major assets in...
TUSTIN, Calif., Aug. 20 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...
TUSTIN, Calif., Aug. 19 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...
Table of Contents U. S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ...
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12B-25 COMMISSION FILE...
TUSTIN, Calif., Aug. 14 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a U.S.-based pharmaceutical company with major operations...
Company's VP of Scientific Oversight to present AMDL's Onko-Sure(TM) in vitro diagnostic cancer test to conference attendees TUSTIN, Calif., July...
TUSTIN, Calif., July 8 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in...
Table of Contents SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of...
Table of Contents SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the...
Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-159286 PROSPECTUS AMDL, INC...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.